- Learn the basics
- Find stocks
- Understand a stock
NEONC TECHNOLOGIES HOLDINGS, INC.
NTHI United States NASDAQNeOnc Technologies Holdings, Inc., a clinical-stage life sciences company, focuses on the development and commercialization of central nervous system therapeutics designed to overcome the blood-brain barrier. The company's NEO drug development platform produces a portfolio of novel drug candidates and delivery methods with patent protections. Its NEO100-01 and NEO100-02 therapeutics are in Phase II, and the NEO100-03 and NEO212 therapeutics are in Phase I clinical trials, advancing under FDA Fast-Track and Investigational New Drug status. NeOnc Technologies Holdings, Inc. was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was founded in 2008 and is based in Westlake Village, California.
In short
Loading the key numbers…
What the sector means for this company
These sentences describe the numbers; they are not a recommendation. This content is not investment advice.
Price chart: each candle shows one day's opening, highest, lowest and closing price. The projection line is our model's estimate - a model, not a promise.
Price chart
Key statistics: the most used ratios in one place. Tap the icon next to a name for a short explanation. Compare them with similar companies, not with the whole market.
Financial statements: the income statement shows sales and profit, the balance sheet what the company owns and owes, and the cash flow statement the money that actually came in and went out. How to read them.
Company policy and leadership: an AI-assisted assessment of how the company sells, executes, uses its resources and treats people, production and service. Read it as a starting point for your own research.
News: the latest articles about the company, grouped by day. Each has ratings for the outlet's stance towards the company and how factual it is. What the ratings mean.